SNT
Click for more information
0.00% 2.3¢ syntara limited

Looks like the price is creeping up again.Phase 3 CF trial...

  1. Lombard1
    764 Posts.
    lightbulb Created with Sketch. 163
    clock Created with Sketch.
    12/03/09
    14:29
    Post #: 4895245
    Looks like the price is creeping up again.

    Phase 3 CF trial results due out within next 3 months.

    Positive result shoudl allowing marketing applications in Aust & Europe.

    Market size Aust&Europe 45,000 patients

    Potential take up 20% = 9,000 patients

    Revenue per patient approx $13,000 (est by PXS on investor calls)

    Revenue per annum potential $117m

    This does not include potential US sales later
    PXS Price at posting: $1.29 Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
2.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $27.46M
Open High Low Value Volume
2.3¢ 2.4¢ 2.3¢ $41.05K 1.755M

Buyers (Bids)

No. Vol. Price($)
2 654545 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 123383 1
View Market Depth
Last trade - 15.46pm 26/06/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.